Abstract
There is increasing interest from the world’s pharmaceutical industry in the problems of bone pathology, and many of the large companies and many smaller biotechnology companies have active bone research programmes. This chapter has been structured to encompass the requirements for both investigational (i.e. research) and preclinical assessment of factors with putative action (therapeutic or otherwise) on bone resorption or formation associated with bone modelling and remodelling. Models of fracture and repair of segmental defects are beyond the scope of this chapter. Investigational requirements centre around identification of an activity or validation of an activity identified in in vitro systems. Preclinical assessment centres around application of an activity to human disease. Under normal circumstances there is a progression from the investigational studies into preclinical assessment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Boyce, B.F., Aufdemorte, T.B., Garrett, I.R. et al. (1989) Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125), 1142–1150.
Yates, A.J., Gutierrez, G.E., Smolens, P. et al. (1988) Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents. Journal of Clinical Investigation 81), 932–938.
Noda, M. and Camilliere, J.J. (1989) In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124), 2991–2994.
Marcelli, C., Yates, A.J. and Mundy, G.R. (1990) In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice. Journal of Bone and Mineral Research 10), 1087–1096.
Dunstan, C.R., Garrett, I.R., Adams, R. et al. (1995) Systemic fibroblast growth factor (FGF-1) prevents bone loss, increases new bone formation, and restores trabecular architecture in ovariectomized rats. Journal of Bone and Mineral Research 10(Suppl. 1), s198.
Schlechter, N.L., Russell, S.M., Greenberg, S. et al. (1986) A direct growth effect of growth hormone in rat hindlimb shown by arterial infusion. American Journal of Physiology 250), E231–235.
Takano-Yamamoto, T. and Rodan, G.A. (1990) Direct effects of 17 beta-estradiol on trabecular bone in ovariectomized rats. Proceedings of the National Academy of Sciences USA 87), 2172–2176.
Russell, S.M. and Spencer, E.M. (1985) Local injections of human or rat growth hormone or on human somatomedin-C stimulate unilateral tibial epiphyseal growth in hypophysectomized rats. Endocrinology 116), 2563–2567.
Wang, J.S. and Aspenberg, P. (1994) Basic fibroblast growth factor increases allograft incorporation. Bone chamber study in rats. Acta Orthopaedica Scandinavica 65), 27–31.
Guise, T.A., Chirgwin, J.M., Favarato, G. et al. (1992) Chinese hamster ovarian cells transfected with human parathyroid hormone-related protein cDNA cause hypercal-cemia in mice. Laboratory Investigation 67), 477–485.
De la Mata, J., Uy, H.L., Guise, T.A. et al. (1995) Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid-hormone related protein in vivo. Journal of Clinical Investigation 95), 2846–2852.
Yates, A.J., Boyce, B.F., Favaroto, G. et al. (1992) Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hyper-calcemia and increased osteoclastic bone resorption. Journal of Bone and Mineral Research 7), 847–853.
Wang, Z.Q., Ovitt, C., Grigoriadis, A.E. et al. (1992) Bone and haematopoietic defects in mice lacking c-fos. Nature 360), 741–745.
Soriano, P., Montgomery, C, Geske, R. and Bradley, A. (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64), 693–702.
Lewis, D.B., Liggitt, H.D., Effman, E.L. et al. (1993) Osteoporosis induced in mice by overproduction of interleukin 4. Proceedings of the National Academy of Sciences USA 90), 11618–11612.
Beamer, W.G., Donahue, L.R., Rosen, C.J. and Bay link, D.J. (1996) Genetic variability in adult bone density among inbred strains of mice. Bone 18), 397–403.
Liu, C.C. and Howard, G.A. (1991) Bone-cell changes in estrogen-induced bone-mass increase in mice: dissociation of osteoclasts from bone surfaces. Anatomical Record 229), 240–250.
Wronski, T.J., Lowry, P.L., Walsh, C.C. and Ignaszewski, L.A. (1985) Skeletal alterations in ovariectomized rats. Calcified Tissue International 37), 324–328.
Kalu, D.N. (1991) The ovariectomized rat model of postmenopausal bone loss. Bone and Mineral 15), 175–191.
Food and Drug Administration (1994) Guidelines for preclinical and clinical evaluation of agents used in the prevention of post menopausal osteoporosis. Division of Metabolism and Endocrine Drug Products. Draft, April.
Jerome, C.P., Lees, C.J. and Weaver, D.S. (1995) Development of osteopenia in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 17 (Suppl.), 402S–408S.
Balena, R., Toolan, B.C., Shea, M. et al. (1993) The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. Journal of Clinical Investigation 92), 2577–2586.
Jerome, C.P., Carlson, C.S., Register, T.C. et al. (1994) Bone functional changes in intact, ovariectomized, and ovariectomized, hormone-supplemented adult cynomolgus monkeys (Macaca fascicularis) evaluated by serum markers and dynamic histomorphometry. Journal of Bone and Mineral Research 9), 527–540.
Longcope, C, Hoberg, L., Steuterman, S. and Baran, D. (1989) The effect of ovariectomy on spine bone mineral density in rhesus monkeys. Bone 10), 341–344.
Malluche, H.H., Faugere, M.C., Friedler, R.M. and Fanti, P. (1988) 1,25-dihydroxyvitamin D3 corrects bone loss but suppresses bone remodeling in ovariohysterectomized beagle dogs. Endocrinology 122), 1998–2006.
Boyce, R.W., Franks, A.F., Jankowsky, M.L. et al. (1990) Sequential histomorphometric changes in cancellous bone from ovariohysterectomized dogs. Journal of Bone and Mineral Research 5), 947–953.
Shen, V., Dempster, D.W., Birchman, R. et al. (1992) Lack of changes in histomorphometric, bone mass, and biochemical parameters in ovariectomized dogs. Bone 13), 311–316.
Mosekilde, L., Weisbrode, S.E., Safron, J.A. et al. (1993) Evaluation of the skeletal effects of combined mild dietary calcium restriction and ovariectomy in Sinclair S-1 minipigs: a pilot study. Journal of Bone and Mineral Research 8), 1311–1321.
Hornby, S.B., Ford, S.L., Mase, C.A. and Evans, G.P. (1995) Skeletal changes in the ovariectomized ewe and subsequent response to treatment with 17 estradiol. Bone 17 (Suppl.), 389s–394s.
Turner, A.S., Mallinckrodt, C.H., Alvis, M.R. and Bryant, H.U. (1995) Dose response effects of estradiol implants on bone mineral density in ovariectomized ewes. Bone 17 (Suppl.), 421S–427S.
Mackey, M.S., Stevens, M.L., Ebert, D.C. et al. (1995) The ferret as a small animal model with BMU-based remodeling for skeletal research. Bone 17 (Suppl.), 191S–196S.
Kalu, D.N., Liu, C.C., Hardin, R.R. and Hollis, B.W. (1989) The aged rat model of ovarian deficiency bone loss. Endocrinology 124), 7–16.
Mayahara, H., Ito, T., Nagai, H. et al. (1993) In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 9), 73–80.
Weinreb, M., Rodan, G.A. and Thompson, D.D. (1989) Osteopenia in the immobilized rat limb is associated with increased bone resorption and decreased bone formation. Bone 10), 187–194.
LeBlanc, A., Marsh, C, Evans, H. et al. (1985) Bone and muscle atrophy with suspension in the rat. Journal of Applied Physiology 58), 1669–1675.
Young, D.R., Niklowitz, W.J., Brown, R.J. and Jee, W.S.S. (1986) Immobilisation-associated osteoporosis in primates. Bone 7), 109–117.
Waters, D.J., Caywood, D.D. and Turner, R.T. (1991) Effect of tamoxifen citrate on canine immobilization (disuse) osteoporosis. Veterinary Surg 20), 392–396.
Morey-Holton, E.R. and Arnaud, S.B. (1991) Skeletal responses to spaceflight. Adv Space Biol Med 1), 37–69.
Sietsema, W.K. (1995) Animal models of cortical porosity. Bone 17 (Suppl.), 297S–305S.
Insogna, K.L., Stewart, A.F., Vignery, A.M. et al. (1984) Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy. Endocrinology 114), 888–896.
Hilgard, P. Schmitt, W., Minne, H. and Ziegler, R. (1970) Acute hypercalcemia due to Walker carcinosarcoma 256 in the rat. Horm Metab Res 2), 255–256.
Strassman, G., Jacob, C.O., Fong, M. and Bertolini, D.R. (1993) Mechanism of paraneoplastic syndromes of colon-26: involvement of interleukin 6 in hypercalcemia. Cytokine 5), 463–468.
Sasaki, A., Boyce, B.F., Story, B. et al. (1995) Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Research 55), 3551–3557.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Chapman and Hall Ltd
About this chapter
Cite this chapter
Dunstan, C.R., Boyce, B.F. (1998). Animal models for the investigation of the action of factors on bone metabolism. In: Arnett, T.R., Henderson, B. (eds) Methods in Bone Biology. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-38227-2_12
Download citation
DOI: https://doi.org/10.1007/978-0-585-38227-2_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-75770-9
Online ISBN: 978-0-585-38227-2
eBook Packages: Springer Book Archive